Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age

European Journal of Pediatrics

Volumn 168, Issue 11, 2009, Pages 1315-1321

  Song, Dooil ^a   Yeo, Yunku ^a   Ha, Keesoo ^a   Jang, Giyoung ^a   Lee, Junghwa ^b   Lee, Kwangchul ^a   Son, Changsung ^a   Lee, Joowon ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

Age; Coronary abnormalities; Incomplete manifestation; Intravenous gamma globulin nonresponsiveness; Kawasaki disease; Risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; BILIRUBIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; SODIUM;

ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GROUPS BY AGE; HUMAN; INFANT; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; SYMPTOM;

AGE DISTRIBUTION; AGE FACTORS; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; GAMMA-GLOBULINS; HUMANS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; INJECTIONS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 70349614652     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-009-0925-0     Document Type: Article

References (25)

1. MS Anderson JK Todd MP Glode 2005 Delayed diagnosis of Kawasaki syndrome: an analysis of the problem Pediatrics 115 4 428 433 10.1542/peds.2004-1824
2. ED Belay RA Maddox RC Holman, et al. 2006 Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003 Pediatr Infect Dis J 25 3 245 249 16511388 10.1097/01.inf.0000202068.30956.16 (Pubitemid 43379066)
3. JC Burns MP Glode 2004 Kawasaki syndrome Lancet 364 9433 533 544 15302199 10.1016/S0140-6736(04)16814-1 (Pubitemid 39070416)
4. JC Burns EV Capparelli JA Brown, et al. 1998 Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group Pediatr Infect Dis J 17 12 1144 1148 9877364 10.1097/00006454- 199812000-00009 1:STN:280:DyaK1M%2FptlWqsw%3D%3D (Pubitemid 29023891)
5. FY Chang B Hwang SJ Chen, et al. 2006 Characteristics of Kawasaki disease in infants younger than six months of age Pediatr Infect Dis J 25 3 241 244 16511387 10.1097/01.inf.0000202067.50975.90 (Pubitemid 43379065)
6. Council on Cardiovascular Disease in the Young; Committee on Rheumatic Fever E, and Kawasaki Disease; American Heart Association 2001 Diagnostic guidelines for Kawasaki disease Circulation 103 2 335 336
7. K Durongpisitkul J Soongswang D Laohaprasitiporn, et al. 2003 Immunoglobulin failure and retreatment in Kawasaki disease Pediatr Cardiol 24 2 145 148 12457253 10.1007/s00246-002-0216-2 1:STN:280:DC%2BD3s7jslCrsg%3D%3D (Pubitemid 36920035)
8. AF Freeman ST Shulman 2004 Refractory Kawasaki disease Pediatr Infect Dis J 23 5 463 464 15131473 10.1097/01.inf.0000125893.66941.e0 (Pubitemid 38621487)
9. M Fukunishi M Kikkawa K Hamana, et al. 2000 Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset J Pediatr 137 2 172 176 10931407 10.1067/mpd.2000.104815 1:CAS:528:DC%2BD3cXmslaru78%3D (Pubitemid 30659222)
10. J Genizi D Miron R Spiegel, et al. 2003 Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis Clin Pediatr (Phila) 42 3 263 267 10.1177/000992280304200310
11. K Harada 1991 Intravenous gamma-globulin treatment in Kawasaki disease Acta Paediatr Jpn 33 6 805 810 1801561 1:STN:280:DyaK387psleitA%3D%3D
12. VE Honkanen BW McCrindle RM Laxer, et al. 2003 Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease Pediatr Cardiol 24 2 122 126 12457252 10.1007/s00246-002-0063-1 1:STN:280: DC%2BD3s7jslCkuw%3D%3D (Pubitemid 36920031)
13. S Meddows-Taylor CT Tiemessen 2004 Age-related changes in polymorphonuclear neutrophil characteristics in infants born to human immunodeficiency virus type 1 seropositive mothers Pediatr Allergy Immunol 15 2 172 182 15059196 10.1046/j.1399-3038.2003.00136.x (Pubitemid 38480788)
14. H Muta M Ishii T Sakaue, et al. 2004 Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease Pediatrics 114 3 751 754 15342849 10.1542/peds.2003-0118-F (Pubitemid 41529534)
15. H Muta M Ishii J Furui, et al. 2006 Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease Acta Paediatr 95 2 189 193 16449025 10.1080/08035250500327328 (Pubitemid 43189012)
16. JW Newburger M Takahashi MA Gerber, et al. 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 17 2747 2771 15505111 10.1161/01.CIR.0000145143.19711.78 (Pubitemid 39453026)
17. SJ Popper C Shimizu H Shike, et al. 2007 Gene-expression patterns reveal underlying biological processes in Kawasaki disease Genome Biol 8 12 R261 18067656 10.1186/gb-2007-8-12-r261 (Pubitemid 351917513)
18. Research Committee on Kawasaki Disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo
19. EA Rosenfeld KE Corydon ST Shulman 1995 Kawasaki disease in infants less than one year of age J Pediatr 126 524 529 7699529 10.1016/S0022-3476(95)70344-6 1:STN:280:DyaK2M3htlyrtg%3D%3D
20. AH Rowley 2002 Incomplete (atypical) Kawasaki disease Pediatr Infect Dis J 21 6 563 565 12182382 10.1097/00006454-200206000-00015 (Pubitemid 34625838)
21. ST Shulman AH Rowley 2004 Advances in Kawasaki disease Eur J Pediatr 163 6 285 291 15346907 10.1007/s00431-004-1431-z (Pubitemid 38725531)
22. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association 1992 Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update JAMA 268 15 2069 2073 10.1001/jama.268.15. 2069
23. JA Stockheim N Innocentini ST Shulman 2000 Kawasaki disease in older children and adolescents J Pediatr 137 2 250 252 10931420 10.1067/mpd.2000. 105150 1:STN:280:DC%2BD3cvjvVWktg%3D%3D (Pubitemid 30659235)
24. CA Wallace JW French SJ Kahn DD Sherry 2000 Initial intravenous gamma globulin treatment failure in Kawasaki disease Pediatrics 105 6 E78 10835091 10.1542/peds.105.6.e78 1:STN:280:DC%2BD3c3psFeksg%3D%3D
25. MT Witt LL Minich JF Bohnsack PC Young 1999 Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria Pediatrics 104 1 e10 10390296 10.1542/peds.104.1.e10 1:STN:280: DyaK1MzhvFSrsg%3D%3D